Cisplatin Adverse Reaction: Clinical Trials

5 trials for Cisplatin Adverse Reaction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed. 5 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 3, Completed 2
Phase 32Completed 1, Unknown 1

Follow Cisplatin Adverse Reaction: new trials by email Literature Review of Cisplatin Adverse Reaction trials Research Report on Cisplatin Adverse Reaction

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients
N acetyl cysteine - Cisplatin Adverse Reaction, Cisplatin Nephrotoxicity
Phase 2UnknownAin Shams University602024-02-012024-03-07
Comparative Study of Different Doses of Magnesium as a Protective Agent in Nephrotoxicity in Cancer Patients
cisplatin with hydration magnesium, cisplatin 40 mg/m² - Cisplatin Adverse Reaction
Phase 2CompletedTanta University1002022-10-012026-03-23
Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity
Rosuvastatin 10mg - Cisplatin Adverse Reaction
Phase 2UnknownCairo University652020-11-172021-07-28
Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury
Gemigliptin, Placebo, Cisplatin - Cancer, Cisplatin Adverse Reaction
Phase 2 / Phase 3UnknownSeoul National University Bundang Hospital1822014-12-012016-04-20
Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma
Silymarin, Placebo, chemotherapy - Upper GI Cancer, Cisplatin Adverse Reaction
Phase 2 / Phase 3CompletedTehran University of Medical Sciences302013-08-012015-05-13

Narrower conditions

Ototoxicity (2)  ·  Gastrointestinal Neoplasms (1)  ·  Neoplasms (1)  ·  Peripheral Nervous System Diseases (1)

Broader conditions

Chemically-Induced Disorders (2)  ·  Drug-Related Side Effects and Adverse Reactions (2)  ·  Ear Diseases (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Radiation Injuries (2)  ·  Wounds and Injuries (2)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)

Interventions

Cisplatin (3)  ·  Acetylcysteine (1)  ·  Docetaxel (1)  ·  Drug Therapy (1)  ·  Fluorouracil (1)  ·  LC15-0444 (1)  ·  Rosuvastatin Calcium (1)  ·  Silymarin (1)  ·  milk-thistle extract (1)

Sponsors

Ain Shams University (1)  ·  Cairo University (1)  ·  Seoul National University Bundang Hospital (1)  ·  Tanta University (1)  ·  Tehran University of Medical Sciences (1)

Countries

Egypt (3)  ·  Iran (1)  ·  South Korea (1)

Top investigators

Aya T Moustafa, BSc (1)  ·  Dalia S Elhelw, PhD (1)  ·  Ki Young Na (1)  ·  Loay Kassem, PhD (1)  ·  Mohamed H Solayman, PhD (1)  ·  Simin Dashti-Khavidaki, Dr (1)

Results publications

PMID 24092928, PMID 26021829